Needham Reiterates Buy on Boston Scientific, Maintains $61 Price Target
Portfolio Pulse from richadhand@benzinga.com
Needham analyst Mike Matson has reiterated a 'Buy' rating on Boston Scientific (NYSE:BSX) and maintained a price target of $61.
August 28, 2023 | 11:48 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Boston Scientific's stock rating has been reiterated as 'Buy' by Needham analyst Mike Matson, with a maintained price target of $61.
The reiteration of a 'Buy' rating by a reputable analyst like Mike Matson from Needham is a positive signal for investors. The maintained price target of $61 indicates that the analyst believes the stock has potential for growth, which could lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100